本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ascendis Pharma A/S

242.09
+8.593.68%
成交量:141.87萬
成交額:3.35億
市值:149.36億
市盈率:-54.80
高:242.44
開:235.18
低:227.96
收:233.50
52周最高:242.44
52周最低:124.06
股本:6,169.52萬
流通股本:6,008.34萬
量比:1.89
換手率:2.36%
股息:- -
股息率:- -
每股收益(TTM):-4.4176
每股收益(LYR):-4.4176
淨資產收益率:-818.43%
總資產收益率:-6.86%
市淨率:-78.95
市盈率(LYR):-54.80

資料載入中...

2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/11

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2026/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities